- Lobbying
- Lobbying by Alliance for Patient Access
Lobbying Relationship
Bills mentioned
H.R.2077: Restoring the Patient's Voice Act of 2017
Sponsor: Brad Wenstrup (R-Ohio)
H.R.2430: FDA Reauthorization Act of 2017
Sponsor: Greg Walden (R-Ore.)
S.934: FDA Reauthorization Act of 2017
Sponsor: Lamar Alexander (R-Tenn.)
H.R.34: 21st Century Cures Act
Sponsor: Suzanne Bonamici (D-Ore.)
H.R.2028: Further Continuing and Security Assistance Appropriations Act, 2017
Sponsor: Mike Simpson (R-Idaho)
S.3040: Departments of Labor, Health and Human Services, and Education, and...
Sponsor: Roy Blunt (R-Mo.)
H.R.5: Student Success Act
Sponsor: John Kline (R-Minn.)
S.524: Comprehensive Addiction and Recovery Act of 2016
Sponsor: Sheldon Whitehouse (D-R.I.)
H.R.4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of...
Sponsor: David Schweikert (R-Ariz.)
H.R.4710: 340B PAUSE Act
Sponsor: Larry Bucshon (R-Ind.)
S.2453: Ensuring the Value of the 340B Program Act of 2018
Sponsor: Charles E. Grassley (R-Iowa)
S.2554: Patient Right to Know Drug Prices Act
Sponsor: Susan Collins (R-Maine)
S.2553: Know the Lowest Price Act of 2018
Sponsor: Debbie Stabenow (D-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Gavin Clingham | n/a |
Darby O'Donnell | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate